(USA TODAY) -- A new peanut allergy treatment could hold promise for children who otherwise suffer severe reactions.
The experimental drug that shows it's possible to build up a peanut tolerance over time is ready for U.S. Food and Drug Administration review. Final research results published in The New England Journal of Medicine were also presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting on Sunday.
A phase three trial included 551 people, most ages 4 to 17 with a history of life-threatening reactions after eating peanuts. Participants were given the experimental drug derived from peanuts daily over the course of several months.
Advertisement - story continues below